Results 31 to 40 of about 32,721 (222)

Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic

BMJ Paediatrics Open, 2022
Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis, Vassiliki Papaevangelou, Danai Ktena, Eleni Kourkouni, Flora Kontopidou, Kassiani Gkolfinopoulou, Kalliopi Papadima, Theano Georgakopoulou, Ioanna Magaziotou, Anastasia Andreopoulou, Georgina Tzanakaki   +10 more
doaj   +1 more source

Meningococcal and pneumococcal meningitis in Northern Ghana [PDF]

, 2008
Despite improvements in technology, treatments and understanding of how bacterial meningitis develops, the disease remains a potentially life-threatening emergency capable of causing significant morbidity and mortality. N. meningitidis, S.
Forgor, Abdulai Adams
core   +1 more source

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]

, 2015
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M, Ngadoua, C, Kadidja Gamougam, Dominique A. Caugant, Trotter, Caroline L, Toralta, J, Greenwood, B M, Ngadoua, Cyriaque, Fermon, Florence, Manigart, Olivier, Daugla, D M, Olivier Manigart, Daugla, Doumagoum M, Florence Fermon, Page, A-L, Caugant, D A, Djingarey, M H, Doumagoum M. Daugla, Fermon, F, James M. Stuart, Page, Anne-Laure, Trotter, C L, Caugant, Dominique A, Djingarey, Mamoudou H, Anne-Laure Page, Mamoudou Djingarey, Gamougam, Kadidja, Cyriaque Ngadoua, Toralta, Jacques, Stuart, J M, Stuart, James M, Gamougam, K, Manigart, O, Caroline L. Trotter, Jacques Toralta, Brian M. Greenwood   +35 more
core   +1 more source

Meningococcal Disease

Neurosciences, 2002
Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
Ziad A, Memish, Abdulrahman A, Alrajhi
openaire   +3 more sources

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Heuberger, S., Stuart, J.M., G. HANQUET, Nielsen, Stine, Stefanoff, P., P. STEFANOFF, Hanquet, G, Hanquet, Germaine, S. HEUBERGER, Nielsen, S, J. M. STUART, W. HELLENBRAND, Stefanoff, P, Stuart, JM, Hellenbrand, Wiebke, Heuberger, S, S. NIELSEN, Hellenbrand, W, Hanquet, G.   +18 more
core   +1 more source

Meningococcal Disease and Travel [PDF]

Clinical Infectious Diseases, 2002
Invasive meningococcal disease, in both endemic and epidemic forms, is the cause of significant morbidity and mortality worldwide. Despite all advances in therapy, the fatality rate of meningococcal meningitis remains unacceptably high, between 5% and 10%, and a similar proportion suffers long-term neurological sequalae.
openaire   +2 more sources

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity. [PDF]

, 2012
Despite the success of conjugate vaccination against meningococcal group C (MenC) disease, post-vaccination, some individuals still exhibit rapid waning of initially protective bactericidal antibody levels.
Findlow, J., Helen Findlow, Findlow, H., James B Wing, Findlow Jamie, Read, Robert C., Helen Findlow (184554), Read Robert C., Wing, J.B., Borrow, Ray, Heath, A.W., James B. Wing, Robert C. Read (145234), Borrow Ray, Read, R.C., Andrew Lees, Smart Lynne, Borrow, R., Heath, Andrew W., Lynne Smart, Lees, Andrew, Jennifer Carlring, Findlow, Helen, James B. Wing (184537), Wing James B., Findlow, Jamie, Ray Borrow, Robert C. Read, Heath Andrew W., Smart, L., Lees Andrew, Lynne Smart (184541), Ray Borrow (49342), Andrew W. Heath (184566), Jamie Findlow (184547), Smart, Lynne, Lees, A., Andrew Lees (184562), Andrew W Heath, Wing, James B., Andrew W. Heath, Robert C Read, Rachel A Foster, Findlow Helen, Jamie Findlow   +44 more
core   +1 more source

Meningococcal vaccines in China

Human Vaccines & Immunotherapeutics, 2021
Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu, Yanan Li, Shanshan Wang, Maoguang Li, Miao Xu, Qiang Ye   +5 more
doaj   +1 more source

Recommendations for the use of meningococcal vaccines in South Africa

Southern African Journal of Infectious Diseases, 2017
Background: Although meningococcal disease (MD) incidence in South Africa is low, Neisseria meningitidis (NM) causes severe disease that is often life-threatening and can cause long-term disabilities.
Susan Meiring, Gregory Hussey, Prakash Jeena, Salim Parker, Anne von Gottberg   +4 more
doaj   +1 more source

Meningococcemia in a vaccinated child receiving eculizumab and review of the literature

The Turkish Journal of Pediatrics, 2023
Background. Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by uncontrolled activation and dysregulation of the alternative complement pathway and development of thrombotic microangiopathy. Eculizumab, which is
Diana Üçkardeş, Nilüfer Göknar, Nurhan Kasap, Emre Keleşoğlu, Mustafa Arga, Cengiz Candan   +5 more
doaj   +1 more source